Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population, ...

Invivyd, Inc. has announced new in vitro data showing that its monoclonal antibody PEMGARDA™ (pemivibart) maintains effective neutralizing activity against the prevalent LP.8.1 variant of SARS-CoV-2, ...

A team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed, but the ...

If you’ve been spending any time around virologists (or, really, anywhere) over these last few pandemic-stricken years, you may be sick of hearing about a particular viral protein called spike. For ...

A new, faster, and more cost-effective molecular diagnostic tool, Intelli-OVI, has been developed. It offers the potential for continuous monitoring of emerging SARS-CoV-2 variants and provides an ...

The Nimbus variant, or NB.1.8.1, is a strain of SARS-CoV-2, which causes COVID-19. Alongside the usual symptoms of COVID-19, it can cause a razor blade sensation in the throat and gastrointestinal ...

Researchers have developed a powerful tool that can detect variants of SARS-CoV-2 with high transmission potential before they become widespread. This approach could significantly support public ...

During the first few years of the COVID-19 pandemic, the virus SARS-CoV-2 was detected in an increasing number of non-human animal species. This included many wild animal species as well as domestic ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could prevent ...

Covid has largely dropped out of the headlines, but the virus that causes it is still circulating. We ask what we should know about a new variant of SARS-CoV-2, the state of the Covid pandemic in 2025 ...